NDC 49401-102
Benlysta 400 mg per 5 mL injection, powder, lyophilized, for solution
On the label: GlaxoSmithKline LLC.
Where it's made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants GlaxoSmithKline LLC names for other drugs.
Recalls
- Apr 21, 2025 · Class II · Mckesson Medical-Surgical Inc. Corporate Office
CGMP Deviations; potential temperature excursions due to transit delays
Lots: Lot: YK4W, Expiration date: 4/30/2029
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Belimumab: every company that makes it
- Form
- injection, powder, lyophilized, for solution, intravenous
- Strength
- 400 mg per 5 mL
- Approval
- BLA BLA125370
- On the market since
- Mar 10, 2011
- Package NDCs
49401-102-01- Official label
- DailyMed (National Library of Medicine), updated Aug 21, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?